Vicky W. Zhang

Vicky W. Zhang began their career in 2014 as an Investment Banking Analyst at Nomura International plc. In 2015, they joined Goldman Sachs, where they held the roles of Investment Banking Associate and Executive Director, as well as Investment Banking Analyst. In 2021, they became the Chief Financial Officer at Adlai Nortye Biopharma Co., Ltd, a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies.

Vicky W. Zhang attended the University of Oxford from 2013 to 2014, where they obtained a Master of Science (MSc) in Financial Economics.